Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.
Gupta M, Chauhan C, Bhatnagar P, Gupta S, Grover S, Singh PK, Purushottam M, Mukherjee O, Jain S, Brahmachari SK, Kukreti R.
Gupta M, et al. Among authors: singh pk.
Pharmacogenomics. 2009 Feb;10(2):277-91. doi: 10.2217/14622416.10.2.277.
Pharmacogenomics. 2009.
PMID: 19207030